Cargando…
Enzyme–substrate interface targeting by imidazole‐based γ‐secretase modulators activates γ‐secretase and stabilizes its interaction with APP
Alzheimer's disease (AD) pathogenesis has been linked to the accumulation of longer, aggregation‐prone amyloid β (Aβ) peptides in the brain. Γ‐secretases generate Aβ peptides from the amyloid precursor protein (APP). Γ‐secretase modulators (GSMs) promote the generation of shorter, less‐amyloido...
Autores principales: | Petit, Dieter, Hitzenberger, Manuel, Koch, Matthias, Lismont, Sam, Zoltowska, Katarzyna Marta, Enzlein, Thomas, Hopf, Carsten, Zacharias, Martin, Chávez‐Gutiérrez, Lucía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627667/ https://www.ncbi.nlm.nih.gov/pubmed/36121025 http://dx.doi.org/10.15252/embj.2022111084 |
Ejemplares similares
-
APP substrate ectodomain defines amyloid‐β peptide length by restraining γ‐secretase processivity and facilitating product release
por: Koch, Matthias, et al.
Publicado: (2023) -
Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ‐secretase modulators
por: Petit, Dieter, et al.
Publicado: (2019) -
The dynamic conformational landscape of γ-secretase
por: Elad, Nadav, et al.
Publicado: (2015) -
Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
por: Zoltowska, Katarzyna Marta, et al.
Publicado: (2023) -
Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
por: Uemura, Kengo, et al.
Publicado: (2010)